SLG
Stanley-Laman Group Portfolio holdings
AUM
$673M
This Quarter Return
+13.45%
1 Year Return
+14.64%
3 Year Return
+60.49%
5 Year Return
+79.33%
10 Year Return
+186.95%
AUM
$564M
AUM Growth
+$564M
(+25%)
Cap. Flow
+$48.7M
Cap. Flow
% of AUM
8.63%
Top 10 Holdings %
Top 10 Hldgs %
20.67%
Holding
271
New
43
Increased
122
Reduced
34
Closed
33
Top Buys
| 1 |
Qorvo
QRVO
|
$7.54M |
| 2 |
Repligen
RGEN
|
$6.85M |
| 3 |
Paycom
PAYC
|
$6.74M |
| 4 |
TIF
Tiffany & Co.
TIF
|
$4.01M |
| 5 |
VF Corp
VFC
|
$2.14M |
Top Sells
| 1 |
Leidos
LDOS
|
$6.16M |
| 2 |
L3Harris
LHX
|
$5.86M |
| 3 |
BWX Technologies
BWXT
|
$5.17M |
| 4 |
VER
VEREIT, Inc.
VER
|
$3.61M |
| 5 |
Sanofi
SNY
|
$1.88M |
Sector Composition
| 1 | Technology | 29.76% |
| 2 | Healthcare | 15.33% |
| 3 | Financials | 10.47% |
| 4 | Industrials | 9.22% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Vertex Pharmaceuticals
VRTX
$100B
| $512K | 0.09% | 2,168 +964 | +80% | +$228K |
|
152
Intercontinental Exchange
ICE
$101B
| $470K | 0.08% | 4,073 +817 | +25% | +$94.3K |
|
153
Garmin
GRMN
$46.5B
| $454K | 0.08% | 3,797 +778 | +26% | +$93K |
|
154
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $450K | 0.08% | 9,521 +849 | +10% | +$40.1K |
|
155
Pool Corp
POOL
$11.6B
| $447K | 0.08% | 1,200 +220 | +22% | +$82K |
|
156
Masimo
MASI
$7.59B
| $419K | 0.07% | 1,560 +350 | +29% | +$94K |
|
157
Accenture
ACN
$162B
| $396K | 0.07% | 1,516 -1,554 | -51% | -$406K |
|
158
Vanguard Intermediate-Term Bond ETF
BIV
$24.1B
| $356K | 0.06% | +3,668 | New | +$356K |
|
159
Procter & Gamble
PG
$368B
| $310K | 0.05% | +2,226 | New | +$310K |
|
160
Coca-Cola
KO
$297B
| $274K | 0.05% | +5,000 | New | +$274K |
|
161
iShares Core S&P Small-Cap ETF
IJR
$85.2B
| $272K | 0.05% | +2,955 | New | +$272K |
|
162
Integra LifeSciences
IART
$1.18B
| $260K | 0.05% | +4,000 | New | +$260K |
|
163
SPDR NYSE Technology ETF
XNTK
$1.25B
| $254K | 0.05% | +1,953 | New | +$254K |
|
164
Regeneron Pharmaceuticals
REGN
$61.5B
| $242K | 0.04% | 500 | – | – |
|
165
Vanguard Tax-Exempt Bond Index Fund
VTEB
$38B
| $223K | 0.04% | 4,038 -1,213 | -23% | -$67K |
|
166
Elevance Health
ELV
$71.8B
| $219K | 0.04% | +682 | New | +$219K |
|
167
iShares 3-7 Year Treasury Bond ETF
IEI
$16.8B
| $217K | 0.04% | 1,635 -396 | -19% | -$52.6K |
|
168
Carlyle Secured Lending
CGBD
$1.02B
| $208K | 0.04% | +20,225 | New | +$208K |
|
169
Alphabet (Google) Class C
GOOG
$2.58T
| $203K | 0.04% | +116 | New | +$203K |
|
170
Sensient Technologies
SXT
$4.82B
| $197K | 0.03% | +2,667 | New | +$197K |
|
171
Manulife Financial
MFC
$52.2B
| $196K | 0.03% | +10,974 | New | +$196K |
|
172
Blackstone
BX
$134B
| $194K | 0.03% | +3,000 | New | +$194K |
|
173
Tesla
TSLA
$1.08T
| $194K | 0.03% | +275 | New | +$194K |
|
174
Enbridge
ENB
$105B
| $191K | 0.03% | +5,968 | New | +$191K |
|
175
GE Aerospace
GE
$292B
| $143K | 0.03% | +13,268 | New | +$143K |
|